Chimerix Inc at Jefferies Healthcare Conference (Virtual) Transcript
Hi, my name is Maury Raycroft and I am one of the biotech analysts at Jefferies. It's with great pleasure that I'd like to welcome Mike Sherman, the CEO of Chimerix. Chimerix is an interesting company with three late-stage programs, each unique.
And without further ado, I'll turn it over to Mike to tell you more about Chimerix. And for the audience, if you have questions, feel free to submit them online, and I will try to get to some of those at the end. Thanks for joining us today, Mike.
Thanks, Maury. Really appreciate you having us. As you mentioned, we have got some exciting programs. And this year, in particular, a number of those set to hit some milestones, so look forward to giving you an update here. I will make some forward-looking statements, so please refer to our most recent SEC filings for a more complete disclosure of those risks and uncertainties.
As Maury mentioned, we've got a bit of a unique program here. And as I joined the Company a couple of years
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |